|
|
Relief Therapeutics Holding SA
/ Key words: Miscellaneous
APR Applied Pharma Research a Subsidiary of Relief Therapeutics is a Finalist in the 2022 Rare Disease International Film Festival
21.11.2022 / 07:00 CET/CEST
APR Applied Pharma Research a Subsidiary of Relief Therapeutics is a Finalist in the 2022 Rare Disease Interna... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F1 with the U.S. Securities and Exchange Commission
16Nov2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
14Nov2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Ther... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Legal Matter
Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide additional time for the parties to finalize their litigation settlement
08Nov2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the co... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Research Update
Relief Therapeutics Announces SixMonth Stability Data on a New Formulation of RLF100 Aviptadil
07Nov2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Announces... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Legal Matter
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. extend their stay of pending litigation to provide additional time for the parties to finalize their settlement
26Oct2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this annou... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics Files Amendment No. 2 to its Form F6 Registration Statement with the U.S. Securities and Exchange Commission
25Oct2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Rel... Lire le communiqué |
|
| |
|
| |
